TME Pharma N.V. (ALTME.PA)
EUR 0.06
(1.1%)
EUR 0.06
(1.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 17 Thousand | - | 33.00 | 35.00 | 154.00 | - |
| Cost of Revenue | 144 Thousand | 92 Thousand | 66 Thousand | 63 Thousand | 1.02 Million | 982 Thousand |
| Gross Profit | -127 Thousand | -92 Thousand | -65.96 Thousand | -62.96 Thousand | -1.02 Million | -982 Thousand |
| Operating Expenses | 5.49 Million | 11.99 Million | 13.45 Million | 5.75 Million | 2.91 Million | 3.33 Million |
| Selling, General and Administrative Expenses | 2.98 Million | 1.92 Million | 1.26 Million | 912 Thousand | 1.32 Million | 1.29 Million |
| Research and Development Expenses | 2.65 Million | 8.14 Million | 10.65 Million | 4.01 Million | 496 Thousand | 479 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 5.64 Million | 11.99 Million | 13.45 Million | 5.75 Million | 3.94 Million | 4.31 Million |
| Operating Income | -5.62 Million | -12.02 Million | -13.26 Million | -5.76 Million | -3.94 Million | -4.36 Million |
| Interest Expense | 1.51 Million | 3.4 Million | 1.5 Million | 5.05 Million | 3000.00 | 6.75 Million |
| Income Tax Expense | 2000.00 | 7000.00 | 1000.00 | 417 Thousand | 1000.00 | 1000.00 |
| Earnings before Tax | -6.73 Million | -15.12 Million | -14.45 Million | -10.4 Million | -860 Thousand | -10.73 Million |
| Net Income | -6.73 Million | -15.13 Million | -14.45 Million | -10.4 Million | -861 Thousand | -10.73 Million |
| Earnings Per Share Basic | -1.34 | -11.66 | -19.85 | -29.15 | -6.99 | -269.77 |
| Earnings Per Share Diluted | -1.34 | -11.66 | -19.85 | -29.15 | -6.99 | -269.77 |
| Weighted Average Shares Outstanding | 5.01 Million | 1.29 Million | 727.93 Thousand | 356.97 Thousand | 123.09 Thousand | 39.79 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 5.01 Million | 1.29 Million | 727.93 Thousand | 356.97 Thousand | 123.09 Thousand | 39.79 Thousand |
| Gross Margin | -7.47 | - | -1999.00 | -1799.00 | -6680.82 | - |
| EBIT Margin | -298.35 | - | -390.36 Thousand | -151.08 Thousand | -5259.74 | - |
| Profit Margin | -396.24 | - | -437.93 Thousand | -297.28 Thousand | -5590.91 | - |
| EBITDA | -5.07 Million | -11.63 Million | -12.88 Million | -5.28 Million | -810 Thousand | -3.95 Million |
| Earnings Before Tax Margin | -330.82 | - | -402.03 Thousand | -164.82 Thousand | -25.63 Thousand | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | 17 Thousand | 8500.00 | 8500.00 | - | - |
| Cost of Revenue | 66 Thousand | 144 Thousand | - | - | - | - |
| Gross Profit | -66 Thousand | -127 Thousand | 8500.00 | 8500.00 | - | - |
| Operating Expenses | 2.67 Million | 5.49 Million | 1.53 Million | 1.53 Million | 1.82 Million | 1.82 Million |
| Selling, General and Administrative Expenses | 1.57 Million | - | 760 Thousand | 760 Thousand | 734.5 Thousand | 734.5 Thousand |
| Research and Development Expenses | 1.1 Million | - | 668.5 Thousand | 668.5 Thousand | 657.5 Thousand | 657.5 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 2.74 Million | 5.64 Million | 1.53 Million | 1.53 Million | 1.82 Million | 1.82 Million |
| Operating Income | -2.74 Million | -5.64 Million | -1.42 Million | -1.42 Million | -1.39 Million | -1.39 Million |
| Interest Expense | 520 Thousand | 1.51 Million | - | - | - | - |
| Income Tax Expense | 15 Thousand | 2000.00 | 1000.00 | 1000.00 | - | - |
| Earnings before Tax | -3.24 Million | -6.73 Million | -1.53 Million | -1.53 Million | -1.82 Million | -1.82 Million |
| Net Income | -3.24 Million | -6.73 Million | -1.53 Million | -1.53 Million | -1.82 Million | -1.82 Million |
| Earnings Per Share Basic | -0.12 | - | -0.23 | -0.31 | -0.54 | -0.54 |
| Earnings Per Share Diluted | -0.12 | - | -0.23 | -0.31 | -0.54 | -0.54 |
| Weighted Average Shares Outstanding | 27.34 Million | 5.01 Million | 6.67 Million | 5.01 Million | 3.36 Million | 3.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 27.34 Million | 5.01 Million | 6.67 Million | 5.01 Million | 3.36 Million | 3.36 Million |
| Gross Margin | - | -7.47 | 1.00 | 1.00 | - | - |
| EBIT Margin | - | - | -166.15 | -164.92 | - | - |
| Profit Margin | - | -396.24 | -181.00 | -181.00 | - | - |
| EBITDA | -2.66 Million | - | -1.41 Million | -1.4 Million | -1.35 Million | -1.35 Million |
| Earnings Before Tax Margin | - | -331.82 | -167.06 | -167.06 | - | - |
BDSX
CNLHP
6066
WGO
NOW
VCSA